The first hemophilia B patient in Germany received gene therapy Hemgenix, covered by public healthcare with efficacy-tied reimbursement.

The petition was filed by Prema Ram who appeared in the Civil Services Examination conducted by the Union Public Service Commission (UPSC) in May this year ...

Contaminated blood scandal campaigners have challenged the Government to act in response to a new report laying out ...

The Government’s “failure” to listen to victims of the infected blood scandal has been “exposed” in a new report, campaigners have said. The Haemophilia Society said that victims of the scandal, ...

A report into the timeliness of compensation for those infected and affected is due to be published on Wednesday, following ...

Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...

Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance induction, a study found.

Pfizer has reported positive topline outcomes from the multicentre, open-label Phase III BASIS trial of Hympavzi (marstacimab) for adults and adolescents with haemophilia A or B with inhibitors. The ...

If you bruise easily, it could be more than delicate skin. Haemophilia B is a rare bleeding disorder that often goes undiagnosed. Learn about its signs, causes, and treatment with expert insights.

Nigerians living with inherited bleeding disorder also known as Haemophilia are in large numbers with many undiagnosed which is a source of concern to many.

When most people hear the term 'haemophilia,' they think of a rare bleeding disorder that primarily affects men. There is a lack of knowledge about the possibility of women developing haemophilia ...